BioCentury | May 31, 2017
Emerging Company Profile
Stapling β-catenin
...activity and is in Phase I/II trials for hematologic malignancies and solid tumors. Last month, Venn Therapeutics LLC...
...Venn Therapeutics LLC, Mason, Ohio Targets β-catenin (CTNNB1) Michael Leviten, Senior Writer Stapled peptide Aileron Therapeutics Inc. FOG Pharmaceuticals Inc. University of Utah Venn Therapeutics LLC Beta-catenin...
...Venn Therapeutics LLC, Mason, Ohio Targets β-catenin (CTNNB1) Michael Leviten, Senior Writer Stapled peptide Aileron Therapeutics Inc. FOG Pharmaceuticals Inc. University of Utah Venn Therapeutics LLC Beta-catenin...
